MUC1 and cancer: Kunkler and colleagues administered intravesical anti-MUC1 monoclonal antibody (mAb) NCRC48 to 12 patients with radiologically confirmed BCa, demonstrating increased uptake of NCRC48 in cancer tissue compared to normal mucosa [131].